McVest UW Clinical Trial Report | NVAX Message Board Posts


NVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  198892 of 203471  at  12/6/2022 3:18:04 PM  by

redplate


 In response to msg 198887 by  barolo
view thread

Re: McVest UW Clinical Trial Report

Thatís a tough question to answer as I would prefer to have direct comparative data to evaluate. It would make a difference if you had NVAX primary series (plus or minus booster) or if you were primed with mRNA. Iím pretty sure that if you had the NVAX primary series that an NVAX booster would be as good (or damn near) as mRNA bivalent. If however this is your first NVAX after 3 mRNA then Iím far less confident that it would benefit you. For reasons of my own risk factors (need to travel) I took PFE for 3rd after ten months from my second NVAX (could not get a booster from trial). I then took the bivalent mRNA about six weeks ago now again since I could not get an NVAX booster and Ďgrandkidsí are a part of our lives. I wish I could have waited I wish they had a BA5 bivalent available. Wish in one hand shit in the other, see which one fills up first.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
198895 Re: McVest UW Clinical Trial Report mcvest 0 12/6/2022 3:31:56 PM
198916 Re: McVest UW Clinical Trial Report barolo 0 12/6/2022 8:03:56 PM




Financial Market Data provided by
.
Loading...